Divi's Laboratories [DIVISLAB] vs Torrent [TORNTPHARM] Detailed Stock Comparison

Divi's Laboratories Ltd.

NSE
Loading...

Torrent Pharmaceuticals Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Divi's Laboratories Ltd. wins in 11 metrics, Torrent Pharmaceuticals Ltd. wins in 9 metrics, with 0 ties. Divi's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Divi's Laboratories Ltd. Torrent Pharmaceuticals Ltd. Better
P/E Ratio (TTM) 67.11 61.35 Torrent Pharmaceuticals Ltd.
Price-to-Book Ratio 10.82 16.50 Divi's Laboratories Ltd.
Debt-to-Equity Ratio 0.58 33.40 Divi's Laboratories Ltd.
PEG Ratio 4.63 2.35 Torrent Pharmaceuticals Ltd.
EV/EBITDA 48.63 34.44 Torrent Pharmaceuticals Ltd.
Profit Margin (TTM) 24.04% 17.83% Divi's Laboratories Ltd.
Operating Margin (TTM) 29.65% 26.70% Divi's Laboratories Ltd.
EBITDA Margin (TTM) 29.65% 26.70% Divi's Laboratories Ltd.
Return on Equity 14.64% 25.18% Torrent Pharmaceuticals Ltd.
Return on Assets (TTM) 12.94% 12.75% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $2.15B $19.73B Torrent Pharmaceuticals Ltd.
Dividend Yield 0.91% 0.83% Divi's Laboratories Ltd.
1-Year Return -0.43% 40.54% Torrent Pharmaceuticals Ltd.
Price-to-Sales Ratio (TTM) 16.18 10.94 Torrent Pharmaceuticals Ltd.
Enterprise Value $1,635.46B $1,413.15B Divi's Laboratories Ltd.
EV/Revenue Ratio 15.86 11.09 Torrent Pharmaceuticals Ltd.
Gross Profit Margin (TTM) 63.71% 75.42% Torrent Pharmaceuticals Ltd.
Revenue per Share (TTM) $388 $376 Divi's Laboratories Ltd.
Earnings per Share (Diluted) $93.66 $67.11 Divi's Laboratories Ltd.
Beta (Stock Volatility) 0.19 0.19 Divi's Laboratories Ltd.

Divi's Laboratories Ltd. vs Torrent Pharmaceuticals Ltd. Stock Performance Analysis

Loading Price Chart...

DIVISLAB
TORNTPHARM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Divi's Laboratories Ltd.-0.44%1.34%-2.25%8.85%4.11%4.17%
Torrent Pharmaceuticals Ltd.-1.47%2.12%2.23%5.56%19.07%17.04%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Divi's Laboratories Ltd.-0.43%85.44%58.15%496.33%1,610.60%10,946.76%
Torrent Pharmaceuticals Ltd.40.54%146.00%215.51%578.42%2,737.14%10,046.95%

Performance & Financial Health Analysis: Divi's Laboratories Ltd. vs Torrent Pharmaceuticals Ltd.

MetricDIVISLABTORNTPHARM
Market Information
Market Cap i₹1.69T₹1.39T
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i253,443393,915
90 Day Avg. Volume i283,911399,129
Last Close₹6,608.50₹4,504.00
52 Week Range₹5,636.50 - ₹7,071.50₹3,140.10 - ₹4,712.90
% from 52W High-6.55%-4.43%
All-Time High₹7,071.50 (Jul 08, 2025)₹4,712.90 (May 25, 2026)
% from All-Time High-6.55%-4.43%
Growth Metrics
Quarterly Revenue Growth0.12%0.18%
Quarterly Earnings Growth-0.01%0.26%
Financial Health
Profit Margin (TTM) i0.24%0.18%
Operating Margin (TTM) i0.30%0.27%
Return on Equity (TTM) i0.15%0.25%
Debt to Equity (MRQ) i0.5833.40
Cash & Liquidity
Book Value per Share (MRQ)₹580.95₹249.47
Cash per Share (MRQ)₹122.95₹23.47
Operating Cash Flow (TTM) i₹19.67B₹27.02B
Levered Free Cash Flow (TTM) i₹21.91B₹19.11B
Dividends
Last 12-Month Dividend Yield i0.91%0.83%
Last 12-Month Dividend i₹60.00₹35.00

Valuation & Enterprise Metrics Analysis: Divi's Laboratories Ltd. vs Torrent Pharmaceuticals Ltd.

MetricDIVISLAB (Apr 24, 2026)TORNTPHARM (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i67.1161.35
Forward P/E i53.7563.92
PEG Ratio i4.632.35
Price to Sales (TTM) i16.1810.94
Price to Book (MRQ) i10.8216.50
Market Capitalization
Market Capitalization i₹1.69T₹1.39T
Enterprise Value i₹1.64T₹1.41T
Enterprise Value Metrics
Enterprise to Revenue i15.8611.09
Enterprise to EBITDA i48.6334.44
Risk & Other Metrics
Beta i0.190.19
Book Value per Share (MRQ) i₹580.95₹249.47

Financial Statements Comparison: Divi's Laboratories Ltd. vs Torrent Pharmaceuticals Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricDIVISLAB (2025)TORNTPHARM (2025)
Revenue/Sales i93.25B113.17B
Cost of Goods Sold i38.70B28.84B
COGS % of Revenue i41.5%25.5%
Gross Profit i54.55B84.33B
Gross Margin i58.5%74.5%
Research & Development i270.00M304.20M
Operating Income (EBIT) i25.71B29.26B
Operating Margin i27.6%25.9%
EBITDA i33.19B37.25B
EBITDA Margin i35.6%32.9%
Pre-Tax Income i29.16B26.73B
Pre-Tax Income % of Revenue i31.3%23.6%
Income Tax i7.25B7.62B
Income Tax % of Revenue i7.8%6.7%
Net Income (Profit) i21.91B19.11B
Profit Margin i23.5%16.9%

Balance Sheet & Liquidity Metrics

MetricDIVISLAB (2025)TORNTPHARM (2025)
Cash & Equivalents i4.15B5.73B
Total Current Assets i100.81B56.23B
Total Current Assets % of Revenue i108.1%49.7%
Total Current Liabilities i14.52B47.17B
Total Current Liabilities % of Revenue i15.6%41.7%
Long-Term Debt i20.00M13.38B
Long-Term Debt % of Revenue i0.0%11.8%
Total Shareholders Equity i149.69B75.91B
Retained Earnings i134.00BN/A
Retained Earnings % of Revenue i143.7%0.0%
Property, Plant & Equipment i3.19B2.99B

Cash Flow Statement Comparison

MetricDIVISLAB (2025)TORNTPHARM (2025)
Operating Cash Flow i19.67B27.02B
Operating Cash Flow % of Revenue i21.1%23.9%
Capital Expenditures i-14.38B-5.94B
Free Cash Flow i2.15B19.73B
FCF Margin i2.3%17.4%
Debt Repayment iN/A-9.26B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricDIVISLABTORNTPHARM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i265.47M338.45M
Float Shares i117.72M103.94M
% Held by Insiders i52.04%71.13%
% Held by Institutions i28.65%14.81%
% Held by Public i19.31%14.06%

Dividend Analysis & Yield Comparison: Divi's Laboratories Ltd. vs Torrent Pharmaceuticals Ltd.

MetricDIVISLABTORNTPHARM
Last 12-Month Dividend i₹60.00₹35.00
Last 12-Month Dividend Yield i0.91%0.83%
3-Year Avg Annual Dividend i₹50.00₹32.33
3-Year Avg Dividend Yield i0.70%0.52%
3-Year Total Dividends i₹150.00₹97.00
Ex-Dividend DateJul 25, 2025Feb 18, 2026